Have a personal or library account? Click to login
Impact of protein intervention timings on critically ill patients: A systematic review and meta- analysis Cover

Abstract

Background

Critically ill patients experience metabolic alterations that promote muscle atrophy and protein catabolism, increasing morbidity and mortality. While adequate protein provision is essential, the optimal timing remains controversial. Guidelines recommend higher protein targets, but evidence from randomized controlled trials is limited and inconsistent.

Aim

To evaluate the effects of early versus late protein supplementation on mortality, complications, and clinical outcomes in critically ill patients.

Methods

A systematic review and meta-analysis were conducted using PubMed, Embase, Cochrane Library, and Google Scholar (January 2010–December 2022). Studies comparing early and late protein administration in adult ICU patients were included. Primary outcomes were mortality, infectious complications, overall complications, pneumonia, ICU/hospital length of stay, and mechanical ventilation duration.

Results

Thirteen studies (8 RCTs, 3 retrospective, 2 prospective cohorts) involving 10,672 patients were analyzed. Mortality (RR = 0.87, 95% CI: 0.74–1.04, p = 0.11; I2 = 36%), overall complications (RR = 0.87, 95% CI: 0.74–1.02, p = 0.08; I2 = 26%), infectious complications (RR = 0.86, 95% CI: 0.58–1.27, p = 0.37; I2 = 65%), and pneumonia (RR = 0.78, 95% CI: 0.41–1.48, p = 0.34; I2 = 0%) showed no significant differences between early protein (EP) and late protein (LP) groups. EP significantly reduced ICU length of stay (MD = −0.28 days, 95% CI: −0.33 to −0.23, p < 0.00001; I2 = 99%) and mechanical ventilation duration (MD = −0.66 days, 95% CI: −0.90 to −0.41, p < 0.00001; I2 = 85%), but was associated with a longer hospital stay (MD = 0.47 days, 95% CI: 0.31–0.63, p < 0.00001; I2 = 98%).

Conclusion

Early protein supplementation does not significantly affect mortality or major complications but may shorten ICU stay and ventilation duration. High heterogeneity for some outcomes warrants cautious interpretation.

DOI: https://doi.org/10.2478/jccm-2025-0047 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 323 - 336
Submitted on: Jan 1, 2025
Accepted on: Oct 8, 2025
Published on: Oct 31, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Pranav Kumar Sharma, Sanjiya Arora, Tirth Bhavsar, Mamta Kamboj, Rahul Kamboj, Varnika Gupta, Anitha Sigamani Ramamurthi, Kumari Uthayakumar, Ajay Singh, Sachin Mahendrakumar Chaudhary, Arghadip Das, Arianisa Bajrami, Sumesh Singh, Devendra Tripathi, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.